Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases

NCT05769010 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

OTHER_GOV

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: SHR-A1811
DRUG: Pyrotinib
DRUG: Bevacizumab
DRUG: Adebelizumab

Sponsor

Henan Cancer Hospital